Antithrombotic management and outcomes of patients with atrial fibrillation treated with NOACs early at the time of market introduction: Main results from the PREFER in AF Prolongation Registry

The management of patients with atrial fibrillation (AF) has rapidly changed with increasing use of non-vitamin K antagonist oral anticoagulants (NOACs) and changes in the use of rhythm control therapy. The prevention of thromboembolic events European Registry in Atrial Fibrillation Prolongation Reg...

Πλήρης περιγραφή

Αποθηκεύτηκε σε:
Λεπτομέρειες βιβλιογραφικής εγγραφής
Τόπος έκδοσης:Intern Emerg Med
Κύριοι συγγραφείς: Renda, Giulia, Pecen, Ladislav, Patti, Giuseppe, Ricci, Fabrizio, Kotecha, Dipak, Siller-Matula, Jolanta M., Schnabel, Renate B., Wachter, Rolf, Sellal, Jean-Marc, Rohla, Miklos, Lucerna, Markus, Huber, Kurt, Verheugt, Freek W. A., Zamorano, Jose Luis, Brüggenjürgen, Bernd, Darius, Harald, Duytschaever, Mattias, Le Heuzey, Jean-Yves, Schilling, Richard J., Kirchhof, Paulus, De Caterina, Raffaele
Μορφή: Artigo
Γλώσσα:Inglês
Έκδοση: Springer International Publishing 2020
Θέματα:
Im - Original
Διαθέσιμο Online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8049932/
https://ncbi.nlm.nih.gov/pubmed/32955677
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11739-020-02442-9
Ετικέτες: Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια